Centennial, Colo. — September 25, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced two presentations on the use of biologics in spinal fusion surgery at AlloSource’s booth #2031 at the North American Spine Society (NASS) Annual Meeting on Thursday, September 27.

Dr. Wellington K. Hsu will present on Novel Allograft Processing Methods to Improve Osteoinductivity and Clinical Outcomes at 12:10 p.m. Dr. Hsu is a Professor of Orthopaedic Surgery and Neurological Surgery at Northwestern University Feinberg School of Medicine in Chicago, Illinois and specializes in degenerative spine surgery, cervical spine surgery, spine trauma and spinal cord injuries.

Dr. Peter Passias will present on The Growing Role of Allogeneic Stem Cells in Spinal Surgery at 3:10 p.m. Dr. Passias is a Cervical, Lumbar, Adult & Pediatric Scoliosis and Spinal Deformity Specialist at the New York Spine Institute in New York, New York and an Associate Professor of Orthopaedic and Neurological Surgery at NYU School of Medicine. Dr. Passias focuses on the treatment of degenerative conditions of the spine, with an emphasis on complex spinal deformities, including thoracolumbar revision procedures and scoliosis.

AlloSource is highlighting its portfolio of advanced spinal allografts at NASS. The organization’s spinal allograft solutions leverage the proven science of allografts to augment natural healing in spinal fusion. With a variety of allograft offerings, AlloSource provides advanced grafts such as AlloFuse® Select CM, a cellular allograft matrix, AlloFuse Cortical Fibers and Fiber Boat, AlloFuse Plus Demineralized Bone Matrix putty and paste, and AlloFlex® Plus Flexible Matrix. The organization also offers many other allografts, including cervical grafts, wedges, and cortical/cancellous chips.

The NASS Annual Meeting is taking place September 26 – 29, 2018 in Los Angeles, California. Visit AlloSource at booth #2031 for more information.


About AlloSource
AlloSource is dedicated to advancing the science and use of transplantable allogeneic cells and tissue through pioneering research in regenerative therapies. The organization offers life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility. As a world leader in cell-based products, fresh cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource’s products bridge the proven science of allografts with the advanced technology of cells. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit allosource.org.